Tragic Death Sparks Concerns Over Mounjaro Weight-Loss Injections: Understanding the Risks

Susan McGowan’s Tragic Death and Weight-Loss Injections

Last week, the sad news of Susan McGowan’s death shocked many. The 58-year-old nurse from Scotland died after receiving two doses of Mounjaro, a weight-loss drug. Susan began taking tirzepatide in August and by September 4, she faced severe health issues, leading to her death.

Her death certificate noted that the use of prescribed tirzepatide contributed to her death, raising concerns about this new weight-loss treatment. Susan, who worked at University Hospital Monklands for over 30 years, might be the first person in the UK to die with Mounjaro listed as a factor. Ten deaths potentially linked to weight-loss injections have been reported, along with 68 hospitalizations.

Understanding GLP-1 Injections

Mounjaro belongs to a group of drugs called GLP-1 (Glucagon-like peptide-1) injections, initially used for diabetes but now popular for weight loss. While most people find them safe and effective, severe side effects can occur.

Experts suggest that risk can be limited by:

1. Being honest with your doctor about your medical history.
2. Following a healthy diet.
3. Choosing a reputable clinic if seeking private prescriptions.

Risks and Side Effects

Certain individuals, such as smokers and drinkers, are at higher risk. GLP-1 drugs may cause nausea, vomiting, and diarrhea. In rare cases, they can lead to gastroparesis (stomach paralysis) and gallstones. A major concern is pancreatitis, which can be life-threatening. Reports show that 23 out of every 1,000 patients taking Mounjaro developed this condition.

Obese individuals and those with diabetes are more prone to pancreatitis. Family history of the condition, heart disease, alcohol abuse, and smoking are also risk factors. Reducing alcohol and quitting smoking can help lower this risk.

Cautions when Buying Online

Many people are turning to online pharmacies for GLP-1 prescriptions, often without proper screening. Some patients may self-declare their health status, leading to unsafe practices. Proper medical monitoring is crucial when starting these injections, starting at smaller doses and gradually increasing. Online retailers may not provide this level of care, heightening the risk of complications.

Choosing the Right Drug

There are key differences between GLP-1 drugs like Mounjaro and Wegovy. Mounjaro can help patients lose more weight—up to 20% of body weight—compared to Wegovy’s 15%. However, Mounjaro carries a higher risk of pancreatitis.

Recognize Warning Signs

If you take a GLP-1 drug, be alert for symptoms of pancreatitis, such as:

• Severe abdominal pain
• Inability to keep fluids down
• Fever

Seek immediate medical attention if you experience these symptoms.

Maintaining a Healthy Diet

Those using weight-loss injections must monitor their diets closely to avoid malnutrition. These drugs reduce appetite and food intake, making it crucial to eat nutrient-dense meals. Missing essential vitamins and minerals can cause fatigue and other health issues.

It’s vital to avoid heavy meals with refined carbs, which can lead to discomfort. Many in-person weight-loss clinics provide dietary support, but online services often do not. This lack of support increases the risk of nutritional deficiencies and physical complications.

Conclusion

Susan McGowan’s unfortunate death highlights the potential risks associated with weight-loss injections. Those considering medications like Mounjaro or Wegovy should consult healthcare professionals, follow prescribed guidelines, and maintain a nutritious diet to stay safe and healthy.